diabetes treatment News

Eli Lilly Aims to Revolutionize India's Pharmaceutical Market with Innovative Diabetes and Obesity Treatments

Eli Lilly plans to transform India's pharmaceutical market with innovative treatments for diabetes and obesity, leveraging AI and global expertise to address the country's health c...

Eli Lilly Predicts Robust Revenue Growth, Eyes $58-61 Billion by 2025

Eli Lilly and Company forecasts a significant revenue increase to $58-61 billion by 2025, driven by strong sales of its diabetes and obesity treatments, Mounjaro and Zepbound. CEO ...